NovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a report released on Wednesday morning. The firm issued a sell rating on the stock. NovaBay Pharmaceuticals Price Performance Shares of NYSE:NBY opened at $0.47 on Wednesday. NovaBay Pharmaceuticals has a 52-week low of $0.42 and a 52-week high of $4.38. The […]

Related Keywords

United States , ,Novabay Pharmaceuticals Company Profile ,Novabay Pharmaceuticals ,Novabay Pharmaceuticals Price Performance ,Novabay Pharmaceuticals Inc ,News Ratings For Novabay Pharmaceuticals Daily ,Free Report ,Bay Pharmaceuticals ,Get Free Report ,Avenova Spray ,Novabay Pharmaceuticals Daily ,Nyse Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,